Related Experiment Video

Updated: Sep 24, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Invasion and metastasis of a mammary tumor involves TGF-beta signaling

J A McEarchern1, J J Kobie, V Mack

  • 1Department of Microbiology and Immunology, University of Arizona, Tucson 85724, USA.

International Journal of Cancer
|January 10, 2001
PubMed

Insights

Highly metastatic breast cancer cells resist TGF-beta growth inhibition but still require TGF-beta signaling for invasion and metastasis. This suggests TGF-beta plays a crucial role in tumor spread, independent of its growth-blocking effects.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Escape from transforming growth factor-beta (TGF-beta)-mediated cell cycle arrest is linked to tumorigenesis.
  • This escape is often associated with defects in TGF-beta receptors or the SMAD signaling pathway.

Purpose of the Study:

  • To investigate the role of TGF-beta signaling in highly metastatic 4T1 mammary carcinoma cells.
  • To determine if TGF-beta contributes to the metastatic behavior of 4T1 cells despite their resistance to growth inhibition.

Main Methods:

  • Assessed TGF-beta receptor functionality and SMAD-mediated transcription in 4T1 cells.
  • Observed morphological changes and invasion through collagen matrices upon TGF-beta exposure.
  • Utilized a dominant-negative truncated type II receptor to inhibit TGF-beta signaling.

Main Results:

  • 4T1 cells possess functional TGF-beta receptors and initiate SMAD signaling but are resistant to TGF-beta1-induced growth inhibition.
  • TGF-beta exposure induced metastatic phenotypes and increased invasion in 4T1 cells.
  • Inhibiting TGF-beta signaling significantly reduced the formation of distant metastases.

Conclusions:

  • TGF-beta signaling is essential for tumor invasion and metastasis in 4T1 cells, irrespective of their resistance to TGF-beta-mediated growth arrest.
  • TGF-beta signaling promotes the metastatic cascade in mammary carcinoma.
  • Targeting TGF-beta signaling may offer therapeutic strategies for preventing cancer metastasis.

More Related Videos

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...